# GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles

> **NCT00516490** · NA · COMPLETED · sponsor: **V.K.V. American Hospital, Istanbul** · enrollment: 570 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** triptorelin acetate
- **DRUG:** Na Cl %0.9

## Key facts

- **NCT ID:** NCT00516490
- **Lead sponsor:** V.K.V. American Hospital, Istanbul
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 570 (ACTUAL)
- **Last updated:** 2007-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00516490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00516490, "GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00516490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*